Centessa Pharmaceuticals plc
Status: Publicly traded
Direct answer
Centessa Pharmaceuticals plc is publicly traded on NASDAQ under the ticker CNTA.
Centessa Pharmaceuticals plc operates as a clinical-stage pharmaceutical enterprise focused on discovering, developing, and ultimately providing therapeutic solutions to patients. The company's most advanced product candidates include Lixivaptan, a small molecule inhibitor of the vasopressin V2 receptor, which is currently undergoing Phase III clinical evaluation for treating autosomal dominant polycystic kidney...
Can you invest in Centessa Pharmaceuticals plc?
Yes. Centessa Pharmaceuticals plc is publicly traded on NASDAQ under the ticker CNTA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Centessa Pharmaceuticals plc
Detailed equity research is provided by MarketSnap.